Is HbA1c useful for menopause?

HbA1c (glycated hemoglobin) reflects average blood glucose over the past 2–3 months and is a standard tool for diagnosing and monitoring diabetes. During menopause, declining estrogen levels can reduce insulin sensitivity and increase the risk of metabolic disturbances, making HbA1c a potentially useful marker for early detection of impaired glucose tolerance or type 2 diabetes—both of which further elevate cardiovascular risk in this population. The provided context does not directly address HbA1c in menopause; it only notes that menopause raises cardiovascular risk due to estrogen decline. Evidence for HbA1c's utility in menopause is therefore based on general clinical practice and observational studies rather than menopause-specific trials. HbA1c is not a menopause test but a general metabolic indicator. Elevated values warrant medical follow-up, especially before initiating hormone therapy. Consumer lab tests offering HbA1c can provide a screening signal but are not diagnostic. Limitations include potential interference from hemoglobin variants or anemia, which should be considered when interpreting results.